Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia

Brain Research

Volumn 1071, Issue 1, 2006, Pages 75-80

  Yamada, Hideyuki ^a   Chen, Yi Ning ^b   Aihara, Makoto ^b   Araie, Makoto ^b  

^a TOKYO NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hypoxia; Iganidipine; Lomerizine; Neuroprotection; Nimodipine; Retina

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; IGANIDIPINE; LOMERIZINE; NIMODIPINE;

ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; HYPOXIA; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA GANGLION CELL; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNEL BLOCKERS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IONOMYCIN; IONOPHORES; NEUROPROTECTIVE AGENTS; RATS; RETINAL GANGLION CELLS;

ANIMALIA;

EID: 32844467861     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.11.072     Document Type: Article

References (43)

1. B.A. Barres, B.E. Silverstein, D.P. Corey, and L.L. Chun Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning Neuron 1 1988 791 803
2. P.A. Battistella, R. Ruffilli, R. Moro, M. Fabiani, S. Bertoli, A. Antolini, and F.A. Zacchello Placebo-controlled crossover trial of nimodipine in pediatric migraine Headache 30 1990 264 268
3. O. Ben-Yoseph, R.S. Badar-Goffer, P.G. Morris, and H.S. Bachelard Glycerol 3-phosphate and lactate as indicators of the cerebral cytoplasmic redox state in severe and mild hypoxia respectively: a 13C- and 31P-n.m.r. study Biochem. J. 1 1993 915 919
4. A.G. Boehm, K.A. Breidenbach, L.E. Pillunat, A.S. Bernd, M.F. Mueller, and A.U. Koeller Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers Graefe Arch. Clin. Exp. Ophthalmol. 241 2003 34 38
5. S. Bose, J.R. Piltz, and M.E. Breton Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects Ophthalmology 102 1995 1236 1241
6. L. Carter-Dawson, M.L. Crawford, R.S. Harwerth, E.L. Smith III, R. Feldman, F.F. Shen, C.K. Mitchell, and A. Whitetree Vitreal glutamate concentration in monkeys with experimental glaucoma Invest. Ophthalmol. Visual Sci. 43 2002 2633 2637
7. H.S. Chung, A. Harris, D.W. Evans, L. Kagemann, H.J. Garzozi, and B. Martin Vascular aspects in the pathophysiology of glaucomatous optic neuropathy Surv. Ophthalmol. 43 Suppl. 1 1999 S43 S50
8. G.A. Cioffi, and L. Wang Optic nerve blood flow in glaucoma Semin. Ophthalmol. 14 1999 164 170
9. D.W. Cox, P.G. Morris, J. Feeney, and H.S. Bachelard 31P-n.m.r. studies on cerebral energy metabolism under conditions of hypoglycaemia and hypoxia in vitro Biochem. J. 15 1983 365 370
10. V. Danielisova, and M. Chavko KB-2796, a calcium channel blocker, ameliorates ischemic spinal cord damage in rabbits Neurochem. Res. 19 1994 1503 1507
11. J. Flammer The vascular concept of glaucoma Surv. Ophthalmol. 38 Suppl 1994 S3 S6
12. J. Flammer, S. Orgul, V.P. Costa, N. Orzalesi, G.K. Krieglstein, L.M. Serra, J.P. Renard, and E. Stefansson The impact of ocular blood flow in glaucoma Prog. Retinal Eye Res. 21 2002 359 393
13. A.Z. Gaspar, J. Flammer, and P. Hendrickson Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases Eur. J. Ophthalmol. 4 1994 24 28
14. W. Goto, T. Ota, N. Morikawa, Y. Otori, H. Hara, K. Kawazu, N. Miyawaki, and Y. Tano Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina Brain Res. 958 2002 10 19
15. F. Gotoh, Y. Fukuuchi, and K. Tashiro Long-term trial of lomerizine hydrochloride for migraine Jpn. Pharmacol. Ther. 23 1995 1445 1460
16. H. Hara, T. Morita, T. Sukamoto, and F.M. Cutrer Lomerizine(KB2796), a new antimigraine drug CNS Drug Rev. 1 1995 204 226
17. 2+ channel blocker, on cerebral blood flow in rats and dogs Clin. Exp. Pharmacol. Physiol. 26 1999 870 876
18. R.A. Honkanen, S. Baruah, M.B. Zimmerman, C.L. Khanna, Y.K. Weaver, J. Narkiewicz, R. Waziri, K.M. Gehrs, T.A. Weingeist, H.C. Boldt, J.C. Folk, S.R. Russell, and Y.H. Kwon Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy Arch. Ophthalmol. 121 2003 183 188
19. M. Inatani, M. Honjo, Y. Otori, A. Oohira, N. Kido, Y. Tano, Y. Honda, and H. Tanihara Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture Invest. Ophthalmol. Visual Sci. 42 2001 1930 1938
20. 2+ antagonist: ocular and periocular penetration after instillation Invest. Ophthalmol. Visual Sci. 44 2003 1169 1177
21. 2+ antagonist, increases ipsilateral optic nerve head circulation in rabbits and cynomolgus monkeys Curr. Eye Res. 29 2004 67 73
22. K. Kashiwagi, Y. Iizuka, Y. Tanaka, S. Mochizuki, F. Kajiya, M. Araie, Y. Suzuki, H. Iijima, and S. Tsukahara Dual action of nitric oxide on purely isolated retinal ganglion cells Curr. Eye Res. 23 2001 233 239
23. 2(+)- antagonist on visual field in low-tension glaucoma Graefes Arch Clin. Exp. Ophthalmol. 227 1989 408 412
24. H. Levkovitch-Verbin, K.R. Martin, H.A. Quigley, L.A. Baumrind, M.E. Pease, and D. Valenta Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transaction J. Glaucoma 11 2002 396 405
25. X. Luo, G.N. Lambrou, J.A. Sahel, and D. Hicks Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro Invest. Ophthalmol. Visual Sci. 42 2001 2695 2705
26. Y. Mori, G. Mikala, G. Varadi, T. Kobayashi, S. Koch, M. Wakamori, and A. Schwartz Molecular pharmacology of voltage-dependent calcium channels Jpn. J. Pharmacol. 72 1996 83 109
27. M. Nakashima, and M. Kanamaru Clinical phase 1 study of KB-2796 Rinsho Iyaku 5 1989 1791 1811
28. P.A. Netland, N. Chaturvedi, and E.B. Dreyer Calcium channel blockers in the management of low-tension and open-angle glaucoma Am. J. Ophthalmol. 115 1993 608 613
29. N.N. Osborne, M. Ugarte, M. Chao, G. Chidlow, J.H. Bae, J.P. Wood, and M.S. Nash Neuroprotection in relation to retinal ischemia and relevance to glaucoma Surv. Ophthalmol. 43 Suppl. 1 1999 S102 S128
30. Y. Otori, J.Y. Wei, and C.J. Barnstable Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells Invest. Ophthalmol. Visual Sci. 39 1998 972 981
31. Y. Otori, S. Kusaka, A. Kawasaki, H. Morimura, A. Miki, and Y. Tano Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells Brain Res. 31 2003 213 219
32. A. Pielen, M. Kirsch, H.D. Hofmann, T.J. Feuerstein, and W.A. Lagreze Retinal ganglion cell survival is enhanced by gabapentin-lactam in vitro: evidence for involvement of mitochondrial KATP channels Graefe Arch. Clin. Exp. Ophthalmol. 242 2004 240 244
33. J.R. Piltz, S. Bose, and D. Lanchoney The effect of nimodipine, a centrally active calcium antagonist, on visual function and muscular blood flow in patients with normal-tension glaucoma and control subjects J. Glaucoma 7 1998 336 342
34. T. Sakai Yakuri to chiryo 22 1994 4657 4662
35. Y. Tamaki, M. Araie, Y. Fukaya, M. Nagahara, A. Imamura, M. Honda, R. Obata, and G. Tomita Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans Invest. Ophthalmol. Visual Sci. 44 2003 4864 4871
36. G. Tezel, and M.B. Wax Hypoxia-inducible factor 1α in the glaucomatous retina and optic nerve head Arch. Ophtalmol. 122 2004 1348 1356
37. G. Tezel, and X. Yang Caspase-independent component of retinal ganglion cell death, in vitro Invest. Ophthalmol. Visual Sci. 45 2004 4049 4059
38. G. Tomita, Y. Niwa, H. Shinohara, N. Hayashi, T. Yamamoto, and Y. Kitazawa Changes in optic nerve head blood flow and retrobular hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma Int. Ophthalmol. 23 1999 3 10
39. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina Exp. Eye Res. 70 2000 475 484
40. 2+ antagonist, on optic nerve head circulation in rabbits Nippon Ganka Gakkai Zasshi 104 2000 541 546
41. T. Yamamoto, Y. Niwa, H. Kawakami, and Y. Kitazawa The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma J. Glaucoma 7 1998 301 305
42. A. Yamashita, A. Ozaki, A. Ikegami, A. Hayashi, H. Hara, T. Sukamoto, and K. Ito Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats Gen. Pharmacol. 24 1993 1473 1480
43. X.F. Yan, D.Y. Ding, and R.J. Liu Studies on the bioavailability and pharmacokinetics of nimodipine tablet in human body Yaoxue Xuebao 28 1993 45 49